Internal Medicine, Infectious Disease · Ocala, FL
NPI
1174848147
Since 2010
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6591 SW Highway 200
Ocala, FL, 34476
Phone (352) 236-6806
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
1,430 services
Medicare patients, 2024
479
Average age 75
Drug cost, 2024
$496K
927 prescriptions
Company payments, 2025
$29.9
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Javier B Cairo Lavado was code 99232 (hospital e&m - subsequent), 526 times for 216 patients. In total Javier B Cairo Lavado billed 1,430 services in 18 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 526 | 216 | $61.20 | $32K |
| 99233 Hospital E&M - Subsequent | Facility | 416 | 200 | $92.16 | $38K |
| 99223 Hospital E&M - Initial | Facility | 213 | 191 | $134.50 | $29K |
| 99215 Office E&M - Established | Office | 144 | 99 | $127.92 | $18K |
| 99214 Office E&M - Established | Office | 51 | 43 | $87.89 | $4,482 |
| 99205 Office E&M - New | Office | 35 | 35 | $162.94 | $5,703 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 12 | 11 | $157.65 | $1,892 |
By year: 2022 $144K for 1,808 services; 2023 $150K for 1,831 services; 2024 $132K for 1,430 services.
Medicare prescription drug claims, 2024
In 2024, the drug Javier B Cairo Lavado prescribed most often to Medicare patients was Vancomycin Hcl, with 173 prescriptions and refills. In total Javier B Cairo Lavado wrote 927 Medicare prescriptions that cost $496K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 173 | 175 | 48 | $31K |
| Cephalexin Generic | 90 | 107 | 38 | $1,265 |
| Cefepime Hcl Generic | 82 | 82 | 25 | $14K |
| Doxycycline Hyclate Generic | 47 | 56 | 27 | $1,251 |
| Cefazolin Sodium Generic | 45 | 45 | 11 | $1,961 |
| Ceftriaxone Ceftriaxone Sodium | 40 | 40 | 12 | $7,380 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 39 | 39 | 23 | $1,063 |
| Ciprofloxacin Hcl Generic | 36 | 37 | 29 | $506 |
| Amoxicillin Generic | 35 | 41 | 23 | $235 |
| Daptomycin Generic | 25 | 25 | Under 11 | $44K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 24 | 24 | Under 11 | $4,218 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 24 | 24 | Under 11 | $85K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 18 | 26 | 13 | $290 |
| Fosfomycin Tromethamine Generic | 16 | 16 | Under 11 | $2,609 |
| Meropenem Generic | 16 | 16 | Under 11 | $3,268 |
Brand drugs: 100 claims; generic drugs: 827 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Javier B Cairo Lavado $29.9 ($29.9 in general payments such as food, travel and fees) from 2 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $15.59.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $15.59 |
| Gilead Sciences, Inc. GILD | 1 | $14.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.